UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000057766
Receipt number R000065731
Scientific Title The impact of differences in femoral implant design on the peri-implant bone mineral density, muscle strength, and activity level in total hip replacement surgery
Date of disclosure of the study information 2025/05/03
Last modified on 2025/11/06 21:47:58

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The impact of differences in femoral implant design on the peri-implant bone mineral density, muscle strength, and activity level in total hip replacement surgery

Acronym

EU-SCT1

Scientific Title

The impact of differences in femoral implant design on the peri-implant bone mineral density, muscle strength, and activity level in total hip replacement surgery

Scientific Title:Acronym

EU-SCT1

Region

Japan


Condition

Condition

osteoarthritis of the hip

Classification by specialty

Orthopedics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Total hip arthroplasty (THA) is an important treatment for relieving the pain and restoring range of motion limitations caused by hip osteoarthritis and improving patient's quality of life. With an increasing number of procedures being performed due to the aging population, the design of the femoral implant (stem) has become a focal point as a significant factor influencing postoperative outcomes. This study aims to generate evidence that will improve clinical outcomes following THA. It will achieve this by comparing the effects of the shape and surface treatment of the Insignia stem and the Accolade 2 stem on several key factors: initial fixation and mid-term stability of the stem, stem subsidence, bone response around the femoral stem, changes in bone mineral density in the femur, and clinical evaluation. Furthermore, this study intends to provide valuable information for preoperative planning and stem selection in clinical practice. We anticipate that the analysis of radiological evaluations and clinical indicators from multiple perspectives, through randomized trials, will contribute to further advancements in THA outcomes.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The primary outcome is the change in periprosthetic bone mineral density, measured quantitatively at 1, 2, and 5 years postoperatively using bone mineral density testing around the stem. This change will be calculated relative to the bone mineral density around the stem measured on the 7th day after THA surgery, and the effect of differences in stem design on these changes in periprosthetic bone mineral density will be compared between the two groups.

Key secondary outcomes

Secondary outcomes will compare the two groups regarding the impact of stem design differences on radiological evaluations (plain radiographs and CT scans) and on pre- and post-operative clinical evaluations, including muscle strength, patient-reported outcomes, activity level, and other relevant factors.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

YES

Dynamic allocation

YES

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

No need to know


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

The Insignia Stem utilizes a tapered wedge geometry for fixation within the proximal femur. A key design feature is its substantial proximal volume aimed at maximizing metaphyseal fill in lateral view. The stem incorporates a full hydroxyapatite (HA) coating.

Interventions/Control_2

The Accolade 2 Stem utilizes a tapered wedge geometry for fixation within the proximal femur. A key design feature is its flat shape in lateral view. The stem incorporates a 3D porous coating in proximal part.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

50 years-old <=

Age-upper limit

80 years-old >

Gender

Female

Key inclusion criteria

1) Undergoing primary unilateral or bilateral (simultaneous or staged) Total Hip Arthroplasty (THA) at Ehime University Hospital.
2) Diagnosis of advanced to end-stage osteoarthritis of the hip, confirmed radiographically.
3) Presence of hip pain causing functional limitations in activities of daily living (ADLs).
4) Suitable candidacy for either the Insignia Stem or the Accolade II Stem, confirmed by pre-operative CT-based 3D templating.
5) Ability and willingness to provide written informed consent.

Key exclusion criteria

1) Patients unable to achieve outdoor ambulation, even with the assistance of walking aids (e.g., canes, walkers).
2) Patients with cognitive impairment precluding informed consent, or those otherwise unable to express intention to participate; additionally, any patient deemed unsuitable for study inclusion by the principal investigator or sub-investigators.
3) Patients diagnosed with osteoarthritis of the hip secondary to infection or trauma, idiopathic osteonecrosis of the femoral head (ONFH), or high-grade developmental dysplasia of the hip (Crowe type III or IV).
4) Patients assessed by the attending physician, based on pre-operative CT planning, as having poor suitability for femoral implant fixation due to anatomical or bone quality concerns.

Target sample size

74


Research contact person

Name of lead principal investigator

1st name Masaki
Middle name
Last name Takao

Organization

Ehime University Graduate School of Medicine

Division name

Department of Orthopaedic Surgery

Zip code

791-0295

Address

454 Shitsukawa, Toon, Ehime, 791-0295, Japan

TEL

0899605343

Email

takao.masaki.ti@ehime-u.ac.jp


Public contact

Name of contact person

1st name Tatsuhiko
Middle name
Last name Kutsuna

Organization

Ehime University Graduate School of Medicine

Division name

Department of Orthopaedic Surgery

Zip code

791-0295

Address

454 Shitsukawa, Toon, Ehime, 791-0295, Japan

TEL

0899605343

Homepage URL


Email

kutsuna.tatsuhiko.bh@ehime-u.ac.jp


Sponsor or person

Institute

Ehime University

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Institutional Review Board,Ehime University Hospital

Address

454 Shitsukawa, Toon, Ehime

Tel

089-960-5172

Email

rinri@m.ehime-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 05 Month 03 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2025 Year 03 Month 06 Day

Date of IRB

2025 Year 03 Month 25 Day

Anticipated trial start date

2025 Year 04 Month 21 Day

Last follow-up date

2032 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded

2033 Year 12 Month 31 Day


Other

Other related information



Management information

Registered date

2025 Year 05 Month 03 Day

Last modified on

2025 Year 11 Month 06 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000065731